Regulation 2 Amendment of the Health Protection (Coronavirus) (Requirements) (Scotland) Regulations 2021

for the definition of “authorised vaccine” substitute—

• ““authorised vaccine” means a medicinal product for vaccination against coronavirus which is authorised—

  1. (a)

     for supply in the United Kingdom in accordance with a marketing authorisation, or

  2. (b)

     by the licensing authority on a temporary basis under regulation 174 (supply in response to spread of pathogenic agents etc.) of the Human Medicines Regulations 2012^f4,”,

for the definition of “fully vaccinated” substitute—

• ““fully vaccinated” means that a person has—

  1. (a)

     completed a first course of an authorised vaccine with the final dose (or, if that course consists of only one dose, the dose) having been received—

     1. (i)

        before the start of the period beginning with the 14th day before the date on which they seek to enter the late night premises or relevant event, and

     2. (ii)

        no more than 120 days before the date on which they seek to enter the late night premises or relevant event, or

  2. (b)

     completed a first course and a subsequent course of an authorised vaccine with the subsequent course dose having been received before the start of the period beginning with the 10th day before the date on which they seek to enter the late night premises or relevant event,”,

after the definition of “late night premises” insert—

• ““the licensing authority” has the meaning given in regulation 6(2) (the licensing authority and the Ministers) of the Human Medicines Regulations 2012,

• “marketing authorisation” has the meaning given to it in regulation 8(1) (general interpretation) of the Human Medicines Regulations 2012,”,

in sub-paragraph (a) for “course of doses” substitute “first course of an authorised vaccine” in the first place where it appears,

in sub-paragraph (b) for “course of doses” substitute “first course”,

after sub-paragraph (b) insert—

“,

(c)

a person (“P”) has completed a subsequent course of an authorised vaccine if an additional course of an authorised vaccine has, at least 12 weeks after P completed a first course of an authorised vaccine, been administered to P for the purpose of boosting P’s immunity to coronavirus,

(d)

a vaccine is not to be considered an authorised vaccine for the purpose of a subsequent course if it is not for the time being in use for this purpose in the United Kingdom.”.